Structure of key heart protein 'found' Expressindia.com, India - Nov 27, 2008 Washington Scientists have discovered how a key protein in heart muscle actually works to regulate heart function, a breakthrough which they claim should ...
Discoveries May Help Scientists Understand Why Disease Turns Soft ... Howard Hughes Medical Institute, MD - Nov 30, 2008 Several years ago, scientists linked FOP to overactivity of the bone morphogenetic protein (BMP) signaling pathway. BMP signals help control tissue repair ...
The Lab Says Heart Attack, but the Patient Is Fine New York Times, United States - Nov 26, 2008 His levels of a heart protein, troponin, were sky-high. It looked as if he was having a heart attack. The runner ended up in the coronary intensive care ...
Plant foods and cancer prevention Malaysia Star, Malaysia - Nov 29, 2008 The nutritive value of cereal protein can be improved by combining with milk, meat or legumes. Many of the grains that we consume today are refined. ...
New Insight Into the Controls on a Go-To Enzyme MarketWatch - Nov 19, 2008 However, such a critical enzyme needs ultra-precise control, which is the job of another protein called calpastatin. A central question has been how ...
Recent News and Articles on the Keywords: heart + 0.37 + 72,400 Related to the article below (Last Update: 8/7/2008)
AtriCure Reports Record Second Quarter 2008 Financial Results PR Newswire (press release), NY - Aug 5, 2008 Revenues from domestic open-heart products were a record $7.4 million, an 8.9% increase over second quarter 2007 revenues of $6.8 million and a 7.2% ...ATRC
Hansen Medical Reports 2008 Second Quarter Results MarketWatch - Jul 31, 2008 Net loss for the second quarter of 2007, including non-cash stock compensation expense of $1.7 million, was $7.9 million, or $(0.37) per basic and diluted ...HNSN
Stocks Set to Open Higher Ahead of Fed Decision BusinessWeek - Aug 5, 2008 On Monday, the Dow Jones industrial average closed 42.17 points, or 0.37%, lower at 11284.15. The broader S&P 500 ended down 11.30 points, or 0.90%, ...
Ziegler meeting all of his early goals OaklandAthletics.com - Jul 13, 2008 The 28-year-old, who began the season with Sacramento and was 2-0 with a 0.37 ERA in 19 relief appearances for the River Cats, has somehow found a way to ...
Select another date Seeking Alpha, NY - Jul 25, 2008 Crude +0.37% to $125.95. Gold +0.78% to $929.50. 8:42 AM Black & Decker (BDK): Q2 EPS of $1.46 beats by $0.04. Revenue of $1.64B (-3.4%) in-line. ...
Evidence of reduced respiratory muscle endurance in patients with heart failure - DM Mancini, D Henson, J LaManca, S Levine - Journal of the American College of Cardiology, 1994 - Am Coll Cardio Found ... ie, time in inspiration divided by the time per breath) was comparable in the two
groups (normal subjects 0.34 +/- 0.09, heart failure group 0.37 +/- 0.12, p ...
[CITATION] Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the … - MJ Stampfer - International Journal of Epidemiology, 2004 - IEA ... Framingham Heart Study b Wilson et al. ... Bush et al. (30) 40?69 2270 26% 8.5 CVD
death (50) 0.34 (0.12?0.81) 0.37 (0.16?0.88) Petitti et al. ...
Restricted Diffusion in Biophysical Systems: Experiment - RL Cooper, DB Chang, AC Young, CJ Martin, B Ancker … - Biophysical Journal, 1974 - Biophysical Soc ... tissue: human blood plasma and red cells; rat and rabbit heart; rat and rabbit liver. ...
Average values of diffusivity ratio in heart were: 0.36 4 0.02 for rat; ...
Sudden death as a result of heart disease in morbid obesity. - J Duflou, R Virmani, I Rabin, A Burke, A Farb, J … - American Heart Journal, 1995 - pt.wkhealth.com ... was greater than the correlation with myocyte size (r = 0.48 vs 0.37, respectively),
and this was also true for heart weight (0.46 vs 0.37, respectively; Fig. ...
Major cardiovascular damage: modified troponin I protein improves heart function
Researchers from the University of Michigan ( U-M ) Medical School suggest this amino acid, called histidine, could be the key to a new therapy for cardiovascular disease.
In a study, published in the Nature Medicine, U-M researchers described how they created a modified form of a heart muscle protein called troponin I and how it improved cardiac function in mice and in damaged human heart cells. The secret was using genetic engineering technology to replace one amino acid called alanine, found in the adult form of troponin I, with a histidine from the fetal form of the same protein.
" The most important finding of our study was that this modified troponin I protein dramatically improved heart function under a variety of conditions associated with cardiovascular damage and heart failure," says Sharlene Day, co-first author of the Nature Medicine paper.
" This study provides the first evidence that a single histidine substitution in troponin I can improve short and long-term cardiac function in laboratory mice with heart failure," says Joseph M. Metzger, at the U-M Medical School. " The fact that we also were able to rescue the functionality of damaged human heart cells is a significant advance."
Metzger believes modified troponin I protein could become the basis of a new gene therapy or cell-based therapy for heart disease and heart failure.
Progressive heart failure affects 4.8 million Americans. Despite current medical and surgical therapies, mortality remains high.
Troponin I is an important cardiac muscle regulatory protein that controls the calcium sensitivity of heart muscle cells. The ability to respond to calcium is important, because it's what causes the heart to contract efficiently and pump blood through the body. When blood flow to the heart is compromised, such as during a heart attack, acid accumulates in cardiac cells – a condition called acidosis. This causes cells to become less responsive to calcium, which can lead ultimately to heart damage and cardiac failure.
During embryonic development, the fetal form of troponin I is present in the fetal heart, which makes it more resistant than the adult heart to the harmful effects of acidosis and low oxygen that can occur during pregnancy or delivery. This means that fetal hearts largely retain their ability to respond to calcium under adverse conditions.
" Shortly before or after birth, the gene for fetal troponin I is turned off and the adult gene is turned on," says Margaret Westfall, co-first author of the Nature Medicine paper. " Although the adult form of troponin I is more susceptible to the harmful effects of acidosis, it has other important properties that enable the adult heart to respond to hormones during exercise and periods of stress."
U-M researchers created a "genetic hybrid" of troponin I to combine the advantages of the fetal and adult form of the protein.
The modified protein helps the heart respond to a harsh intracellular environment by boosting its performance during periods of stress.
" By making this single histidine substitution in the adult form of troponin I, we retain hormonal responsiveness and provide protection from acidosis in the same molecule," Day says. " Several heart conditions can cause acidosis in the adult heart, most notably when the heart is deprived of oxygen and nutrients due to compromised blood flow. When ischemia is prolonged, it can cause permanent heart muscle damage in the form of a heart attack."
In a series of experiments, U-M researchers studied the effects of the histidine substitution in troponin I on 1) transgenic mice with the modified form of the protein and normal littermates without the modified protein, 2) hearts removed from both types of research mice, and 3) heart cells called myocytes, which were isolated from rats and from severely damaged human hearts of U-M Health System patients who received heart transplants.
In experiments with isolated myocytes, Westfall used a virus to deliver the modified troponin I gene. When she analyzed cells for expression of troponin I with the histidine substitution, Westfall discovered that "you don't need 100 percent gene replacement to see a biological effect in individual myofilaments. We see favorable effects at 20 percent to 50 percent replacement," she says.
To create the damaging conditions that develop in heart muscle cells when clogged blood vessels or a heart attack interrupt the heart's oxygen supply, Day tied off one of the main arteries carrying blood to the hearts of mice in the study. Day found that hearts from transgenic mice performed far better after the procedure than hearts from mice without modified troponin I.
The U-M research team also found that hearts from transgenic mice contracted more efficiently and used less energy to perform more work than hearts from non-transgenic littermates.
The U-M research team is studying the effects of the genetically engineered troponin I protein in other research animals and exploring mechanisms responsible for its heart-protective effect. They believe the modified troponin I protein senses changes within cardiac muscle cells and responds by improving the cells' ability to contract efficiently in response to stress.
Source: University of Michigan Health System, 2006
Comment by Elizabeth G. Nabel M.D.